All Cancer Microbiology articles
-
NewsYellow pigment from Streptomyces coelicolor offers potential weapon against breast cancer
A new study aims to explore the effect of a yellow pigment (OR3), from a new isolate of Streptomyces coelicolor JUACT03 on metastatic breast cancer.
-
NewsGrowing body of evidence links HPV with heart disease
In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study.
-
NewsProbe into human cervical stem cells shows lactic acid bacteria can prevent cervical cancer
Researchers have revealed the identity and differentiation process of human cervical stem cells in a world first study. The results showed that lactic acid bacteria can inhibit the development of cervical cancer.
-
NewsMovie reveals DNA unzipping mechanism with implications for viral and cancer treatments
A detailed unwinding mechanism of the double-stranded DNA has been uncovered for the first time using cutting-edge technology, revealing how cells begin the crucial process of copying their genetic material.
-
NewsHelicobacter pylori treatment practices in the Asia-Pacific region
Researchers conducted an online survey of clinicians in the Asia-Pacific region to investigate treatment policies for H. pylori and confirmed that there is a growing consensus of the importance of primary and secondary prevention against H. pylori.
-
NewsNew study highlights gaps in HPV-related cancer prevention for people living with HIV
A new study reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities. It highlights existing disparities in healthcare for this vulnerable population.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsHidden dangers and myths: What you need to know about HPV and cancer
While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that ...
-
NewsStudy uncovers how low-carb diet drives colorectal cancer development
A new study suggests that a low-carbohydrate diet promotes the growth of a strain of E. coli that produces DNA-damaging colibactin, which drives genetic mutations and predisposes tumour development.
-
NewsResearchers reveal key mechanism behind bacterial cancer therapy
A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
-
NewsWorld first clinical trial will study specialized ‘poop pills’ to improve treatment of advanced pancreatic cancer
A world-pioneering fecal microbiota transplantation pill will undergo a clinical trial, aiming to improve immune responses by remodifying the gut microbiome in patients with advance pancreatic cancer.
-
NewsGastric bacteria ‘leaking across stomach lining’ could indicate risk of gastric cancer
A new discovery in the roles of gastric microbiota bacteria and Helicobacter pylori across the stomach lining during pre-cancerous stage of gastric cancer development could be the missing link for engineering future therapeutic intervention.
-
NewsStudy reveals how bacteria in microbiome medicine trigger tumor-killing cells
Microbiotica has presented new data on the mechanism of action of MB097, a clinical-stage drug candidate being developed as a co-therapy in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma.
-
NewsLong-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer
A new study finds that yogurt consumption over time may protect against colorectal cancer through changes in the gut microbiome. Long-term consumption of two or more servings per week of yogurt was tied to lower rates of proximal colorectal cancer positive for Bifidobacterium.
-
NewsFungal protein yields new ways to modulate cell activity remotely
A new study introduces tools that remotely and non-invasively communicate with and control the activity of engineered cells once they’ve entered the body. It focuses on a fungal protein the team have developed called Melt, which can be toggled by temperature.
-
NewsCould faecal microbiota transplantation help patients heal after stem cell transplantation?
A study, from a part of an ongoing clinical trial, has reported the safety of oral faecal microbiota transplantation (FMT) to help patients recover from the loss of gut microbiome after allogeneic stem cell transplantation for blood cancers.
-
NewsA therapeutic HPV vaccine could eliminate precancerous cervical lesions
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
-
NewsHepatitis B is a problem for a growing number of patients on immunosuppressive medications
The American Gastroenterological Association (AGA) has unveiled an updated clinical practice guideline addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive drugs.
-
NewsResearch using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials
A promising research study in treating high mortality late-stage cancers with a non-toxic bacterial therapy - BacID - has proven to be safe and more targeted. The newly developed treatment would undergo clinical trials with cancer patients in 2027.
-
NewsOral cancer and microbiome: new insights into tumor growth mechanisms
A recent study has made significant strides in uncovering how the oral microbiome plays a crucial role in the progression of oral squamous cell carcinoma (OSCC), unveiling metabolic pathways and mechanisms that may serve as potential therapeutic targets.